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CLINICAL ARTICLE
J Neurosurg Pediatr 29:543–550, 2022

Pediatric colloid cysts: a multinational, multicenter study.
An IFNE-ISPN-ESPN collaboration
Jonathan Roth, MD,1,2 Yurii Perekopaiko, MD,1 Danil A. Kozyrev, MD,1 and
Shlomi Constantini, MD, MSc,1,2 on behalf of the Pediatric Colloid Cyst Study Group (PCCSG)
Department of Pediatric Neurosurgery, Dana Children’s Hospital, Tel Aviv Medical Center; and 2Tel Aviv University, Tel Aviv,
Israel
1

OBJECTIVE Colloid cysts (CCs) are rare at all ages, and particularly among children. The current literature on pediatric
CC is limited, and often included in mixed adult/pediatric series. The goal of this multinational, multicenter study was to
combine forces among centers and investigate the clinical course of pediatric CCs.
METHODS A multinational, multicenter retrospective study was performed to attain a large sample size, focusing on CC
diagnosis in patients younger than 18 years of age. Collected data included clinical presentation, radiological characteristics, treatment, and outcome.
RESULTS One hundred thirty-four children with CCs were included. Patient age at diagnosis ranged from 2.4 to 18
years (mean 12.8 ± 3.4 years, median 13.2 years, interquartile range 10.3–15.4 years; 22% were < 10 years of age).
Twenty-two cases (16%) were diagnosed incidentally, including 48% of those younger than 10 years of age. Most of the
other patients had symptoms related to increased intracranial pressure and hydrocephalus. The average follow-up duration for the entire group was 49.5 ± 45.8 months. Fifty-nine patients were initially followed, of whom 28 were eventually
operated on at a mean of 19 ± 32 months later due to cyst growth, increasing hydrocephalus, and/or new symptoms.
There was a clear correlation between larger cysts and symptomatology, acuteness of symptoms, hydrocephalus, and
need for surgery. Older age was also associated with the need for surgery. One hundred three children (77%) underwent
cyst resection, 60% using a purely endoscopic approach. There was 1 death related to acute hydrocephalus at presentation. Ten percent of operated patients had some form of complication, and 7.7% of operated cases required a shunt at
some point during follow-up. Functional outcome was good; however, the need for immediate surgery was associated
with educational limitations. Twenty operated cases (20%) experienced a recurrence of their CC at a mean of 38 ± 46
months after the primary surgery. The CC recurrence rate was 24% following endoscopic resection and 15% following
open resections (p = 0.28).
CONCLUSIONS CCs may present in all pediatric age groups, although most that are symptomatic present after the age
of 10 years. Incidentally discovered cysts should be closely followed, as many may grow, leading to hydrocephalus and
other new symptoms. Presentation of CC may be acute and may cause life-threatening conditions related to hydrocephalus, necessitating urgent treatment. The outcome of treated children with CCs is favorable.
https://thejns.org/doi/abs/10.3171/2021.12.PEDS21482
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olloid cysts (CCs) are benign cystic lesions typically located at the upper anterior part of the third
ventricle, adjacent to the foramina of Monro. Their
location can cause obstruction of both foramina of Monro,
leading to bilateral hydrocephalus. CCs usually present
with symptoms related to increased intracranial pressure
(ICP) due to obstructive hydrocephalus. These symptoms

usually appear acutely, although a subacute and even a
chronic presentation over weeks or longer may occur.1–6
Not all CCs cause symptoms, as some may not lead to hydrocephalus, while others may lead to hydrocephalus with
a paucity or even absence of any symptoms.7–10
Given the strong potential for the development of acute
hydrocephalus and even life-threatening conditions and

ABBREVIATIONS CC = colloid cyst; ESPN = European Society for Pediatric Neurosurgery; EVD = external ventricular drain; ICP = intracranial pressure; IFNE = International Federation of Neuroendoscopy; IQR = interquartile range; ISPN = International Society for Pediatric Neurosurgery.
SUBMITTED October 11, 2021. ACCEPTED December 22, 2021.
INCLUDE WHEN CITING Published online February 11, 2022; DOI: 10.3171/2021.12.PEDS21482.
©AANS 2022, except where prohibited by US copyright law

J Neurosurg Pediatr Volume 29 • May 2022

543

Brought to you by University of Western Ontario | Unauthenticated | Downloaded 10/20/22 03:45 PM UTC

Roth et al.

herniation with CCs,11 they should be treated, especially if
they are observed to grow over time or if they lead to hydrocephalus.8 Treatment usually includes resection, either
via a craniotomy through various microsurgical approaches,2,12 or endoscopically.7 CSF drainage with a shunt, and
often a septostomy, is another treatment alternative, especially in the elderly or in instances of CCs that may not
be safely resected. Currently, there is no single accepted
surgical approach for CC resection, as much depends on
the size of the ventricles as well as the surgeon’s experience.13–18
CCs presenting during childhood are rare. They usually present with hydrocephalus but may also present incidentally.6,19–26 A few case reports describing deaths related
to CCs have been published, even during childhood.27–33
Thus, awareness about this rare pathology by the treating
teams should be increased. This study focuses on understanding pediatric CCs in the context of the presenting
symptoms, radiological findings, natural history of nonoperated cases, surgical approach, and outcomes. As the
experience of individual centers treating pediatric CCs is
limited because of the relative rarity of the diagnosis, we
organized an international collaboration among medical
centers and retrospectively collected pediatric CC data.

Methods

This is a multinational, multicenter, retrospective study.
Following IRB approval, we retrospectively reviewed the
files of all children who were treated (or followed) since
2010 for a CC at the Department of Pediatric Neurosurgery of Dana Children’s Hospital, Tel Aviv Medical
Center. Patient or caregiver consent was waived. An introductory letter and study protocol were distributed via
the IFNE (International Federation of Neuroendoscopy),
ISPN (International Society for Pediatric Neurosurgery),
and ESPN (European Society for Pediatric Neurosurgery) mailing lists to all their members, offering them the
opportunity to join this study. Additional centers were
recruited via direct contact with pediatric neurosurgeons
from around the world. Anonymized patient clinical data
were sent to the central office (Dana Children’s Hospital)
for analysis.
Inclusion Criterion
The inclusion criterion was children younger than 18
years of age when diagnosed with a CC. CC diagnosis was
based on one or more of the following: typical MRI findings, intraoperative findings, or pathological confirmation.
Data Collection
We collected the following data: 1) patient demographics and symptoms, including presenting symptoms (or
indication for imaging), symptom acuteness (no symptoms, chronic [months or more], subacute [approximately
2 weeks], acute [days or less], and acute on chronic), level
of presenting symptoms (intact, consciousness, confused
state, and other [specified]), and specific presenting symptoms; 2) imaging (MRI-based) data, including T1- and T2weighted images (hypo-, iso-, or hyperintense), enhancement, maximal cyst size, and presence of hydrocephalus
544

(none, unilateral, or bilateral); 3) treatment-related data,
including treatment methods (surgical or conservative),
timing of surgical treatment, surgical technique, surgeryrelated complications, cyst recurrence (radiological), and
need for further surgeries; and 4) functional outcome as
reported by each center based on patient follow-up charts,
including statements regarding limitations in the following areas: daily function, education, academic difficulties,
and permanent memory problems.
Contributing Centers
A total of 134 cases were recruited from 33 centers,
each contributing 1–20 cases (mean 4 ± 4 cases). Only 2
centers contributed more than 10 cases (12 and 20 each).
Centers were distributed over 5 continents (Table 1).
Statistical Analysis
Data were tabulated in a Microsoft Excel spreadsheet.
IBM SPSS Statistics software (version 25, IBM Corp.) was
used for all statistical analyses. Categorical variables were
reported as number and percentage. Continuous variables
were reported as median and interquartile range (IQR).
Correlations between continuous variables were evaluated
using Spearman’s correlation coefficient. Associations between categorical variables were assessed using Fisher’s
exact test. Associations between categorical and continuous variables were assessed using a Mann-Whitney or
Kruskal-Wallis test. All statistical tests were two-tailed
and a p value < 0.05 was considered significant.

Results

A total of 134 children (74 boys and 60 girls) with CCs
were reported and included in this study. Patient age at
diagnosis ranged from 2.4 to 18 years (mean 12.8 ± 3.4
years, median 13.2 years, IQR 10.3–15.4 years). Table 2
summarizes the ages of the patients in the study, organized according to age group.
Clinical Presentation
Table 3 summarizes the presenting symptoms. Twentytwo cases were diagnosed as incidental CC. Indications
for imaging in the incidental cases included traumatic
brain injury (n = 7), skull lesion (eosinophilic granuloma,
n = 2), learning difficulties and/or developmental delay
(n = 3), unknown (n = 3), and other (scoliosis, ruptured
arteriovenous malformation, endocrine workup, retinal
hemorrhages, fever workup, cholesteatoma, follow-up of
postmeningitis hydrocephalus, n = 1 each).
Twenty-two patients presented with decreased sensorium. In 8 patients this condition presented as a syncope
or seizure in the absence of other symptoms. In 8 cases
the patient presented as lethargic, in some cases with pupil
dilation. In 1 case (a 6.8-year-old), the patient presented
in a coma with dilated and fixed pupils. This patient died,
despite insertion of an urgent external ventricular drain
(EVD). The vast majority of the patients were intact at diagnosis, experiencing various symptoms. Twenty patients
had no presenting symptoms and were all neurologically
intact. Table 4 presents the main signs at presentation for
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TABLE 1. Number of contributing centers and cases, organized
according to continents and countries
Continent/
Region
Africa
Asia

Europe

North America
South America

Total

Country
(no. of centers)

No. of
Cases

Open/Endoscopic
Surgery*

Algeria (1)
India (1)
Pakistan (1)
Israel (1)
France (1)
Germany (4)
Italy (5)
The Netherlands (1)
Spain (2)
Switzerland (1)
Turkey (1)
United Kingdom (2)
Belgium (1)
Canada (2)
USA (5)
Argentina (1)
Brazil (2)
Paraguay (1)
33 centers

7
9
3
8
2
10
23
1
2
1
4
4
5
5
44
3
2
1
134

7/0
9/0
1/2
1/5
0/2
2/6
1/22
0/1
0/1
0/0
1/3
3/1
4/0
0/3
10/10, 2 unknown
0/2, 1 unknown
1/1
0/1
103

* The open/endoscopic column states the number of craniotomy (open) surgeries versus endoscopic resections among these centers.

the 114 symptomatic patients, organized according to the
acuteness of symptom occurrence.
There was a significant correlation between age at diagnosis and occurrence of any symptom. Younger children
were more commonly diagnosed with an incidental CC:
48.3% of children younger than 10 years had no symptoms, compared to 5.7% of children older than 10 years (p
< 0.001). Older children more commonly presented with
headaches (p < 0.001). There was no significant correlation between age and presentation with specific symptoms
of nausea/vomiting, visual complaints, decreased consciousness, memory decline, or presence of papilledema.
There was no significant correlation between the age at
presentation and acuteness of symptoms (chronic, acute,
acute on chronic, subacute); however, the number of children younger than 6 years of age (n = 6 children) was too
small to make any definitive conclusions (Table 5).

TABLE 2. Number of patients according to various age groups
Age (yrs)

No. (%)

0–6
6–12
12–18
<10
>10

6 (4)
44 (33)
84 (63)
30 (22)
104 (78)

TABLE 3. Presenting symptoms
Presenting Symptom

No. (%)

Headache
Nausea/vomiting
Decreased sensorium
Behavioral changes
Visual complaints
Memory decline
Incidental

100 (75)
52 (39)
22 (16)
20 (15)
31 (23)
2 (1.5)
22 (16)

MRI Characteristics
We identified the following MRI characteristics: 1)
82% of the cysts were iso- or hyperintense on T1-weighted
imaging; 2) 75% of the cysts were iso- or hyperintense
on T2-weighted imaging; 3) 15% of the cysts had some
enhancement; and 4) 55% of the patients presented with
some form of hydrocephalus (8% unilateral and 47% bilateral). Cyst size ranged from 2 to 40 mm (mean 12.6 ± 7.3
mm, median 11 mm, IQR 7–17 mm).
There was no significant correlation between age at
presentation and radiological appearance (T1-weighted/
T2-weighted/enhancement) or maximal cyst size. There
was no significant correlation between MRI appearance
(T1-weighted/T2-weighted/enhancement) and type of presenting symptoms, papilledema, presence of hydrocephalus, or acuteness of symptoms. There was a significant
correlation between maximal cyst size and acuteness of
symptoms, as well as presence (and type) of hydrocephalus (p < 0.001 for both). Generally, larger cysts were correlated with more acute symptoms and with more severe
hydrocephalus (bilateral > unilateral > no hydrocephalus).
Larger cysts were also correlated with headaches (p =
0.03), nausea/vomiting (p = 0.001), decreased consciousness (p < 0.001), papilledema (p < 0.001), and any symptom (p < 0.001, as opposed to incidental CC), reflecting
secondary effects of hydrocephalus.
Need for Surgery
Overall, 103 patients underwent a cyst resection, 75 at
presentation. The remaining 59 children were initially followed. Of these 59 children, 28 had a resection at some
point from 1 to 106 months after presentation (mean 19
± 32 months, median 4.5 months, IQR 2–20.7 months).
Reasons for delayed surgery included new symptoms (12
cases), cyst growth (8 cases, 2–106 months after diagnosis,
mean 56 ± 40 months), ventricular enlargement (9 cases),
and family decision or time to referral to neurosurgical
care (3 cases, 1–106 months after diagnosis, mean 28 ± 46
months); some had several causes.
Nine patients underwent shunt surgery. Eight shunts
were placed as the primary treatment for CC-related hydrocephalus, and 1 had a shunt for post-prematurity intraventricular hemorrhage (his cyst was never operated). Of
the 8 treated for the CC, 3 patients were subsequently referred to another neurosurgical facility for cyst resection,
and 5 were initially followed. All underwent delayed resection due to cyst growth or new cyst-related symptoms.
J Neurosurg Pediatr Volume 29 • May 2022
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TABLE 4. Presenting signs and acuteness of symptoms in 114 symptomatic patients
Presenting Sign

Chronic

Subacute

Acute

Acute on Chronic

Total

Papilledema

Intact
Decreased consciousness
Confused state
Other*
Total
Papilledema

37
0
0
0
37
5

27
2
0
5
34
14†

19
8
7
3
37
17

3
3
0
0
6
2

86
13
7
8
114
38

21
9
2
6
38

* Four patients had a squint, 2 had nystagmus, 1 psychiatric illness, and 1 ataxia.
† Two patients had unknown fundus examination.

The range of the follow-up period for the 31 nonoperated cases was 0–132 months (mean 48.6 ± 44 months,
median 32.7 months). The range of the follow-up period
for the entire group was 0–244 months (mean 49.5 ± 45.8
months, median 34 months, IQR 13–72 months). Two variables were correlated with the need for surgery at any time
(initially or subsequently): 1) cyst size, i.e., larger cysts
were associated with need for surgery (p < 0.001); and 2)
older age at presentation (p = 0.002). There was no significant correlation between MRI appearance (T1-weighted/
T2-weighted/enhancement) and a need for surgery.
Surgical Technique
For 100 of the 103 operated cases, the surgical technique was identified in the patient records. There were 62
endoscopic approaches (2 converted to open microsurgical resection), 16 transcortical transventricular approaches, 16 interhemispheric transventricular approaches, 5 interhemispheric interforniceal approaches, and 1 occipital
transtentorial approach. We were unable to find any clear
correlations between the contributing centers and surgical
techniques (Table 1). Many different endoscopic systems
of different sizes were used, from various companies.
A septostomy was performed in 45 patients (48% of 93
reported cases), an endoscopic third ventriculostomy in
8 patients (9% of 90 reported cases), and an EVD in 41
patients (41% of 99 reported cases). A small number of
surgeons reported using an endoscopic ultrasonic aspira-

tor or a side-cutting aspirator, and a few reported using an
endoscopic holder.
Surgical Outcome
There were 10 cases (10%) with 1 or more complications reported. Meningitis was reported in 2 cases, and
infarction, seizures, minor hemorrhage, bone flap migration, acute hydrocephalus requiring an EVD, transient
hemiparesis, strokes following herniation at presentation,
and wound infection in 1 case each. One patient operated
endoscopically had an intraoperative bleed; thus, the surgery was aborted and the cyst was uneventfully resected
via an open approach 10 days later. Seven cases needed a
new shunt following surgery (7.7%). CC radiological recurrence was identified in 20 patients (20%) at 0.3–178
months (mean 38 ± 46 months) after resection, of which
17 underwent an additional resection. The recurrence rate
was 24% following endoscopic resection and 15% following open resections (p = 0.28). One death occurred in a
6.8-year-old who presented in a deep coma with fixed, dilated pupils, and who subsequently died despite an EVD.
No other deaths were reported.
Functional Outcome
Table 6 summarizes the functional outcome as a function of the need for surgery. The data are subdivided based
on whether the surgery was immediate or delayed. There
was no significant correlation between a need for surgery

TABLE 5. Correlation between acuteness of symptoms and age at presentation

546

Symptoms

Age at
Presentation

None

Chronic

Subacute

Acute

Acute on Chronic

Age, yrs
Mean ± SD
Median (IQR)
Minimum age, yrs
% <6 yrs
% 6–12 yrs
% >12 yrs
% <10 yrs
% >10 yrs

9.1 ± 3.6
8 (7–12.4)
2.4
60
27.3
5.9
48.3
5.7

13.3 ± 2.7
13.2 (11.2–15.8)
7
0
27.3
29.4
20.7
29.5

13.9 ± 3.1
14 (12.5–16.8)
5.5
20
11.4
32.9
13.8
28.6

13.3 ± 2.9
14 (11.5–15.7)
6.7
0
31.8
27.1
13.8
31.4

12 ± 4.4
13 (8.7–15.2)
4.3
20
2.3
4.7
3.4
4.8
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TABLE 6. Functional outcome as a function of the need for surgery, and whether it was immediate
or delayed
Need for Surgery
Immediate surgery
Delayed surgery
No surgery

Daily Function

Education

67 normal, 5 limitations 66 normal, 5 special
education
27 normal
27 normal
27 normal, 4 limitations* 19 normal, 4 special
education*

Permanent Memory
Problems

Academic
Difficulties

58 no, 11 yes

56 no, 8 yes

25 no, 1 yes
26 no, 1 yes

26 no, 1 yes
23 no, 4 yes

* All 4 cases were the same patients, and all had a premorbid neurodevelopmental delay unrelated to the CC.

at any time and any outcome decline. There was a slight
correlation between immediate surgery and memory decline (p = 0.03), and a slight correlation between delayed
surgery and educational limitations (p = 0.038). Of the 7
cases presenting with lethargy or pupillary dilation who
survived the acute phase, 1 had limitations in all outcome
variables, whereas the remaining 6 had no reported functional limitations. All nonoperated cases with functional
impairment had a premorbid neurodevelopmental delay
unrelated to the CC explaining their limitations.

Discussion

This is the largest series to date focusing on pediatric
CCs, the main presenting symptoms, radiological characteristics, treatment, and outcomes. CCs are rare among
children; only by collaborating with 33 centers from 5
continents were we able to reach the relatively large number of 134 cases. Most centers contributed small numbers
of fewer than 10 cases.
The main take-home messages from this study are that
CCs may present even in young infants, and most symptomatic cysts present after the age of 10 years. Headaches
were the most common presenting symptom, although
other symptoms of increased ICP (nausea/vomiting, visual complaints, behavioral changes, and decreased sensorium) were reported as well. For the symptomatic group,
62% had hydrocephalus (uni- or bilateral) and 35% had
papilledema. Approximately 20% of all children were
asymptomatic. Of the symptomatic group, symptom occurrence subdivided relatively evenly, occurring acutely,
subacutely, and chronically (about one-third each). Approximately 77% of the patients were treated with surgery
at some point, 60% of which were endoscopic resections.
Of the children who were only followed after diagnosis, about 50% eventually underwent surgery due to new
symptoms, cyst growth, or developing hydrocephalus. The
most important risk factors in the need for surgery were
cyst size and older age. Generally, the functional outcome
reported was good in the vast majority of cases, with the
most common limitations related to memory decline.
Children undergoing urgent treatment were more likely to
develop functional limitations.
These results emphasize the importance of early referral for children of all ages who appear with new-onset
neurological symptoms, or symptoms related to increased
ICP, for urgent evaluation and imaging. Our study clearly

indicates that although rare, CCs may present acutely even
at very young ages, and should lead to early diagnosis and
treatment.
Several publications regarding pediatric CCs have
been published since 1933.34 As the use of MRI for various indications has increased, and the threshold for cranial scanning has become lower over the years, incidental
brain lesions are more commonly diagnosed,35 potentially
leading to diagnosis of more incidental CCs compared to
previous historical series.26 Since the year 2000, a total
of 94 pediatric CCs have been reported in the literature,
including 63 males and 31 females.6,19–26,36–39 Age at presentation was 3–18 years (about 8.5% were younger than
10 years of age). Note that 7 cases (7.5%) were diagnosed
incidentally in this earlier study (compared to the 20% incidental findings in our study). The majority of patients
presented with increased ICP-related symptoms associated with the secondary hydrocephalus. Other series have
included children and adults together, usually with small
numbers of pediatric cases, and have not focused on the
unique clinical or radiological features of the pediatric
patients.4,5,40–42 Of course, incidental CCs are common in
adults too, found in large natural history series.8
Interestingly, drop attacks and syncope have been described in pediatric and adult CCs, often but not always
in association with hydrocephalus.6,19,22 In the current
study, in 134 patients we found 13 instances (10%) of patients presenting with seizures or syncope. Death related
to CC is probably secondary to acute hydrocephalus and
may present in childhood.33 The vast majority of patients
have symptoms preceding death, usually associated with
increased ICP. It is important to increase awareness of
this pattern, because in children, especially compared to
adults, these symptoms last longer prior to death (a mean
of about 6 days).33 However, an ultrafast course of deterioration over several hours, and even a true sudden death,
has been described as well.30,31,37 Some reports state that
pediatric CC may present in a more aggressive manner
and thus may more often lead to sudden death compared
to adult cases.21,31,32 In a large meta-analysis, however, age
was not associated with a bad neurological outcome.43
Treatment of CCs includes both open approaches and
endoscopic resections,2–4,6,7,23,25,40 all with good functional
outcome. There is no clear advantage of one technique
over another,40 and there is no unique treatment strategy
for pediatric versus adult cases. Generally speaking, enJ Neurosurg Pediatr Volume 29 • May 2022

547

Brought to you by University of Western Ontario | Unauthenticated | Downloaded 10/20/22 03:45 PM UTC

Roth et al.

doscopic resections have been advocated in the presence
of hydrocephalus, but endoscopy has also been used in the
absence of hydrocephalus, with good results.7,42 The goal
of surgery is complete removal of the cyst and its capsule;
recurrence may occur in incomplete resections.4 Similar
to a recent series,26 the results of the current multicenter
series share a favorable outcome following endoscopic
resections. Conversely, the radiological recurrence rate of
this series appears to be relatively high for both surgical
approaches, i.e., 24% following endoscopic resection and
15% following open resections (p = 0.28). We do not have
an explanation for this recurrence rate; possibly it reflects
the rarity of this disease and its treatment. Our series also
stresses the role of shunt surgery in the presence of acute
hydrocephalus, when CC resection is not feasible, later referring the patients for further evaluation and treatment to
experienced centers.
For asymptomatic cysts, follow-up is a valid option,
with periodic clinical and radiological evaluation, as these
patients may develop progressive (and even acute) symptoms. Based on the current series, we are unable to state
the length of follow-up needed, or whether there are any
radiological risk factors for cyst growth, development of
hydrocephalus, or symptom progression.
Study Limitations
This study has all the relevant limitations of a retrospective study. Potentially, nonoperated cases may have been
underreported if they were not followed by the neurosurgical teams participating in this study. In addition, because
this was a multicenter study, and cases were treated by
various surgeons and teams, there were no unified indications for treatment. Data were reported by each team, with
no central review of images, and no objective and absolute definition of complications. The diagnosis of CC based
on radiological findings may mislead, as other pathologies
such as low-grade astrocytoma, which are more common in
children, may mimic CC.44,45 The results of this study are
biased by the experience of the treating teams, i.e., whether
to treat endoscopically or via various open microsurgical
approaches. The surgeon’s experience may have also affected results and complications. A few cases also received
shunts as their primary treatment. In at least some cases,
the shunt was reported to have been placed at other medical
centers (probably less experienced) to treat the acute lifethreatening condition. These patients were later referred to
tertiary centers for treatment of their cyst. Outcome assessments were not objective, and were determined based on
the surgeon’s clinic notes, using very simplistic measures.
The absence of formal neuropsychological evaluations of
CC patients in this series (before, during follow-up, and after surgery) is common in most CC series. We recommend
that surgeons treating and following patients with CCs send
these patients for formal evaluations.

Conclusions

CCs may present in all age groups, although most symptomatic ones present after the age of 10 years. Even if cysts
are incidentally discovered, they should be followed, as
many may grow, leading to hydrocephalus or causing new
548

symptoms. The presentation of CC may be acute, and may
cause life-threatening conditions related to hydrocephalus,
necessitating urgent treatment. Outcomes are favorable in
treated children with CCs.
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